Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Short term Debt (2018 - 2025)

Rockwell Medical's Short term Debt history spans 10 years, with the latest figure at $1.8 million for Q3 2025.

  • For Q3 2025, Short term Debt fell 23.04% year-over-year to $1.8 million; the TTM value through Sep 2025 reached $1.8 million, down 23.04%, while the annual FY2024 figure was $2.4 million, 5.16% down from the prior year.
  • Short term Debt reached $1.8 million in Q3 2025 per RMTI's latest filing, down from $2.5 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $21.1 million in Q2 2021 to a low of $171000.0 in Q1 2021.
  • Average Short term Debt over 5 years is $4.6 million, with a median of $2.5 million recorded in 2023.
  • Peak YoY movement for Short term Debt: skyrocketed 11046.1% in 2021, then plummeted 77.9% in 2022.
  • A 5-year view of Short term Debt shows it stood at $7.4 million in 2021, then tumbled by 77.9% to $1.6 million in 2022, then soared by 53.28% to $2.5 million in 2023, then decreased by 5.16% to $2.4 million in 2024, then dropped by 26.19% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Short term Debt are $1.8 million (Q3 2025), $2.5 million (Q2 2025), and $2.4 million (Q1 2025).